Inside the Biomedical Emporium formulation laboratory.

A new formula starts as a clinical question, usually one that landed in Dr Judey's inbox from a practitioner: what would you write for this concern, at this severity, in this skin type? The question sits on paper for a week before anything is weighed.

The next stage is bench chemistry. Iterations, one at a time, until the actives sit stable at the target concentration under target conditions. Then a five-stage tolerance protocol on volunteer skin, then a twelve-week clinical trial with a photographic record. The formula that survives all five stages goes to production. The rest do not.

Dermagate receives the finished product for UAE distribution. Nothing between the laboratory batch and the bathroom shelf changes.

Read next

Building a routine around a single retinoid.

One retinoid does not need another exfoliant, another acid, or another peel. Let the retinoid do its work; support what it withdraws.